Caption Management »

Summit Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.5M 1.2M 7.80

More positions owned by Caption Management

First Solar Call Option (FSLR)
Alnylam Pharmaceuticals Call Option (ALNY)
Citigroup Com New Call Option (C)
Verizon Communications Put Option (VZ)
Caterpillar Call Option (CAT)
Insmed Com Par $.01 Call Option (INSM)
Snowflake Cl A Call Option (SNOW)
Capri Holdings SHS Call Option (CPRI)
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Sarepta Therapeutics Call Option (SRPT)
United States Steel Corporation Call Option (X)
AmerisourceBergen Call Option (COR)
Alphabet Cap Stk Cl C Put Option (GOOG)
Adobe Systems Incorporated Put Option (ADBE)
Celestica Call Option (CLS)

View all positions for Caption Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
T. Rowe Price Associates
Millennium Management
Caption Management
Northern Trust
Balyasny Asset Management
Frigate Ventures
Charles Schwab Investment Management
Susquehanna International
Rafferty Asset Management

View all funds holding Summit Therapeutics